An Aehr Test Systems Director Is Among the Insiders Selling with 20,000 Shares Sold for Over $2 Million. Here Are Insights into the Transaction.

The director disposed of 20,000 shares at a transaction value of ~$2.2 million on August 4, 2026. The sale reduced the insider's total direct equity position by 12%.

The Motley Fool • Aug 5, 2026

An Aehr Test Systems Insider Sells Shares Worth $2.5 Million as the Stock Soars. Here's a Closer Look at the Transaction.

The transactions involved the disposition of 30,000 shares on July 16, 2026, with a total valuation of ~$2.5 million. The dispositions were executed from indirect holdings and included 20,000 shares sold by a spouse and 10,000 shares gifted to the Scott Family Fund.

The Motley Fool • Aug 4, 2026

Aehr Stock Jumps as Silicon Photonics Order Signals Manufacturing Scale-Up

Aehr Test Systems (NASDAQ:AEHR) shares jumped on Tuesday after the company secured a follow-on FOX-XP production order from its lead silicon photonics customer.

Benzinga • Aug 4, 2026

Aehr Test Systems Expands Silicon Photonics Production Momentum with Follow-On Production Order from Lead Customer

FREMONT, CA / ACCESS Newswire / August 4, 2026 / Aehr Test Systems (NASDAQ:AEHR), a leading provider of test and burn-in solutions for semiconductor devices used in artificial intelligence (AI), silicon photonics, data center, automotive, and industrial applications, today announced it has received a follow-on production order from its lead silicon photonics wafer-level burn-in (WLBI) customer for a fully automated FOX-XP® multi-wafer production burn-in system to support the continued expansion of the customer's manufacturing capacity for next-generation silicon photonic integrated circuits. The AI industry is rapidly transitioning from moving electrons to moving photons, driving a significant expansion in silicon photonics as hyperscale data centers seek higher bandwidth, lower latency, improved power efficiency, and greater scalability.

Accesswire • Aug 4, 2026

Microsoft vs. Aehr Test Systems: Comparing Revenue Trends Between These Artificial Intelligence Companies

Microsoft currently displays greater revenue consistency compared to its counterpart, characterized by continuous upward momentum without the steep declines seen in the smaller entity. Over the last eight quarters, Microsoft maintained an unbroken pattern of quarter-over-quarter expansion, while Aehr Test Systems recorded highly volatile results featuring sharp alternating increases and decreases.

The Motley Fool • Aug 4, 2026

Aehr Test Systems vs. C3.ai: Which Technology Stock Is a Better Buy in 2026?

Aehr Test Systems provides essential wafer-level testing for high-growth sectors like silicon carbide and silicon photonics. C3.ai is transitioning its enterprise software platform toward a consumption-based pricing model to drive broader adoption.

The Motley Fool • Aug 2, 2026

Can Aehr Test Systems (AEHR) Climb 49.6% to Reach the Level Wall Street Analysts Expect?

The average of price targets set by Wall Street analysts indicates a potential upside of 49.6% in Aehr Test Systems (AEHR). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Zacks Investment Research • Jul 31, 2026

Why Aehr Test Systems (AEHR) Might be Well Poised for a Surge

Aehr Test Systems (AEHR) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Zacks Investment Research • Jul 31, 2026

FORM vs. AEHR: Which Semi Test Equipment Stock is a Better Buy?

Aehr's record bookings, AI-driven backlog and expanding burn-in portfolio give it the edge over FormFactor for long-term growth.

Zacks Investment Research • Jul 30, 2026

Here's Why Aehr Test Systems (AEHR) Could be Great Choice for a Bottom Fisher

After losing some value lately, a hammer chart pattern has been formed for Aehr Test Systems (AEHR), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.

Zacks Investment Research • Jul 28, 2026